This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Eduardo Vottero: Innovator in IDO Inhibitors
Introduction
Eduardo Vottero is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of indoleamine 2,3-dioxygenase (IDO) inhibitors. His work focuses on addressing various medical conditions through innovative therapeutic approaches.
Latest Patents
Eduardo Vottero holds 1 patent related to IDO inhibitors. His patent details the use of these inhibitors and pharmaceutical compositions for treating conditions characterized by pathology in the IDO-mediated tryptophan metabolic pathway. These conditions may include suppression of T-cell mediated immune response, depletion of tryptophan, and accumulation of tryptophan degradation products. Specific diseases targeted by his invention include cataracts, neurodegenerative disorders, mood disorders, cancer, and various bacterial and viral infections. The novel compounds developed in this patent include substituted naphthalene and anthracene diones, with a particular focus on taurine-substituted naphthaquinone structures.
Career Highlights
Eduardo Vottero is affiliated with the University of British Columbia, where he continues to advance his research and innovation in the pharmaceutical field. His work has the potential to impact various therapeutic areas significantly.
Collaborations
Eduardo has collaborated with notable colleagues, including Raymond John Andersen and Grant Mauk, to further enhance the research and development of IDO inhibitors.
Conclusion
Eduardo Vottero's contributions to the field of pharmaceuticals through his innovative work on IDO inhibitors highlight his role as a key inventor in addressing critical health challenges. His research continues to pave the way for new therapeutic options.